Found: 7
Select item for more details and to access through your institution.
The Nucleoside/Nucleotide Analogs Tenofovir and Emtricitabine Are Inactive against SARS-CoV-2.
- Published in:
- Molecules, 2022, v. 27, n. 13, p. 4212, doi. 10.3390/molecules27134212
- By:
- Publication type:
- Article
Independent inhibition of the polymerase and deubiquitinase activities of the Crimean-Congo Hemorrhagic Fever Virus full-length L-protein.
- Published in:
- PLoS Neglected Tropical Diseases, 2020, v. 14, n. 6, p. 1, doi. 10.1371/journal.pntd.0008283
- By:
- Publication type:
- Article
Efficient Incorporation and Template‐Dependent Polymerase Inhibition are Major Determinants for the Broad‐Spectrum Antiviral Activity of Remdesivir.
- Published in:
- FASEB Journal, 2022, v. 36, p. N.PAG, doi. 10.1096/fasebj.2022.36.S1.R4278
- By:
- Publication type:
- Article
Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir.
- Published in:
- Viruses (1999-4915), 2019, v. 11, n. 4, p. 326, doi. 10.3390/v11040326
- By:
- Publication type:
- Article
Sandacrabins – Structurally Unique Antiviral RNA Polymerase Inhibitors from a Rare Myxobacterium**.
- Published in:
- Chemistry - A European Journal, 2022, v. 28, n. 11, p. 1, doi. 10.1002/chem.202104484
- By:
- Publication type:
- Article
Mutations in the SARS-CoV-2 RNA-dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 656, p. 1, doi. 10.1126/scitranslmed.abo0718
- By:
- Publication type:
- Article
Evolution of naturally arising SARS-CoV-2 defective interfering particles.
- Published in:
- Communications Biology, 2022, v. 5, n. 1, p. 1, doi. 10.1038/s42003-022-04058-5
- By:
- Publication type:
- Article